Literature DB >> 12529321

Distinct phosphoinositide 3-kinases mediate mast cell degranulation in response to G-protein-coupled versus FcepsilonRI receptors.

David A Windmiller1, Jonathan M Backer.   

Abstract

Phosphoinositide (PI) 3-kinases are critical regulators of mast cell degranulation. The Class IA PI 3-kinases p85/p110beta and p85/p110delta but not p85/p110alpha are required for antigen-mediated calcium flux in RBL-2H3 cells (Smith, A. J., Surviladze, Z., Gaudet, E. A., Backer, J. M., Mitchell, C. A., and Wilson, B. S. et al., (2001) J. Biol. Chem. 276, 17213-17220). We now examine the role of Class IA PI 3-kinases isoforms in degranulation itself, using a single-cell degranulation assay that measures the binding of fluorescently tagged annexin V to phosphatidylserine in the outer leaflet of the plasma membrane of degranulated mast cells. Consistent with previous data, antibodies against p110delta and p110beta blocked FcepsilonR1-mediated degranulation in response to FcepsilonRI ligation. However, antigen-stimulated degranulation was also inhibited by antibodies against p110alpha, despite the fact that these antibodies have no effect on antigen-induced calcium flux. These data suggest that p110alpha mediates a calcium-independent signal during degranulation. In contrast, only p110beta was required for enhancement of antigen-stimulated degranulation by adenosine, which augments mast cell-mediated airway inflammation in asthma. Finally, we examined carbachol-stimulated degranulation in RBL2H3 cells stably expressing the M1 muscarinic receptor (RBL-2H3-M1 cells). Surprisingly, carbachol-stimulated degranulation was blocked by antibody-mediated inhibition of the Class III PI 3-kinase hVPS34 or by titration of its product with FYVE domains. Antibodies against Class IA PI 3-kinases had no effect. These data demonstrate: (a) a calcium-independent role for p110alpha in antigen-stimulated degranulation; (b) a requirement for p110beta in adenosine receptor signaling; and (c) a requirement for hVPS34 during M1 muscarinic receptor signaling. Elucidation of the intersections between these distinct pathways will lead to new insights into mast cell degranulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529321     DOI: 10.1074/jbc.M211787200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

Review 3.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions.

Authors:  Lu Wang; Yazheng Zhao; Ye Yang; Yuanjia Hu; Xiaohan Zou; Boyang Yu; Jin Qi
Journal:  J Transl Med       Date:  2017-06-28       Impact factor: 5.531

5.  RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.

Authors:  Geetanjali Bansal; Jeffrey A DiVietro; Hye Sun Kuehn; Sudhir Rao; Karl H Nocka; Alasdair M Gilfillan; Kirk M Druey
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

6.  Morphological characterization of Class III phosphoinositide 3-kinase during mouse brain development.

Authors:  Yutaka Inaguma; Hidenori Ito; Ikuko Iwamoto; Ayumi Matsumoto; Takanori Yamagata; Hidenori Tabata; Koh-ichi Nagata
Journal:  Med Mol Morphol       Date:  2015-08-05       Impact factor: 2.309

7.  Systematic analysis of F-box proteins reveals a new branch of the yeast mating pathway.

Authors:  Nambirajan Rangarajan; Claire L Gordy; Lauren Askew; Samantha M Bevill; Timothy C Elston; Beverly Errede; Jillian H Hurst; Joshua B Kelley; Joshua B Sheetz; Sara Kimiko Suzuki; Natalie H Valentin; Everett Young; Henrik G Dohlman
Journal:  J Biol Chem       Date:  2019-08-09       Impact factor: 5.157

Review 8.  Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors.

Authors:  S J Shuttleworth; F A Silva; A R L Cecil; C D Tomassi; T J Hill; F I Raynaud; P A Clarke; P Workman
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

9.  Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.

Authors:  Stefan Kraft; Tony Fleming; James M Billingsley; Shih-Yao Lin; Marie-Hélène Jouvin; Peter Storz; Jean-Pierre Kinet
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.